Financial Express (Holdings) Limited (“we”, “our”, “us” and derivatives) are committed to protecting and respecting your privacy. This Privacy Policy, together with our Terms of Use, sets out the basis on which any personal data that we collect from you, or that you provide to us, will be processed by us relating to your use of any of the below websites (“sites”).


For the purposes of the Data Protection Act 1998, the data controller is Trustnet Limited of 2nd Floor, Golden House, 30 Great Pulteney Street, London, W1F 9NN. Our nominated representative for the purpose of this Act is Kirsty Witter.


We collect information about you when you register with us or use any of our websites / services. Part of the registration process may include entering personal details & details of your investments.

We may collect information about your computer, including where available your operating system, browser version, domain name and IP address and details of the website that you came from, in order to improve this site.

You confirm that all information you supply is accurate.


In order to provide personalised services to and analyse site traffic, we may use a cookie file which is stored on your browser or the hard drive of your computer. Some of the cookies we use are essential for the sites to operate and may be used to deliver you different content, depending on the type of investor you are.

You can block cookies by activating the setting on your browser which allows you to refuse the setting of all or some cookies. However, if you use your browser settings to block all cookies (including essential cookies) you may not be able to access all or part of our sites. Unless you have adjusted your browser setting so that it will refuse cookies, our system will issue cookies as soon as you visit our sites.


We store and use information you provide as follows:

  • to present content effectively;
  • to provide you with information, products or services that you request from us or which may interest you, tailored to your specific interests, where you have consented to be contacted for such purposes;
  • to carry out our obligations arising from any contracts between you and us;
  • to enable you to participate in interactive features of our service, when you choose to do so;
  • to notify you about changes to our service;
  • to improve our content by tracking group information that describes the habits, usage, patterns and demographics of our customers.

We may also send you emails to provide information and keep you up to date with developments on our sites. It is our policy to have instructions on how to unsubscribe so that you will not receive any future e-mails. You can change your e-mail address at any time.

In order to provide support on the usage of our tools, our support team need access to all information provided in relation to the tool.

We will not disclose your name, email address or postal address or any data that could identify you to any third party without first receiving your permission.

However, you agree that we may disclose to any regulatory authority to which we are subject and to any investment exchange on which we may deal or to its related clearing house (or to investigators, inspectors or agents appointed by them), or to any person empowered to require such information by or under any legal enactment, any information they may request or require relating to you, or if relevant, any of your clients.

You agree that we may pass on information obtained under Money Laundering legislation as we consider necessary to comply with reporting requirements under such legislation.


We want to ensure that the personal information we hold about you is accurate and up to date. You may ask us to correct or remove information that is inaccurate.

You have the right under data protection legislation to access information held about you. If you wish to receive a copy of any personal information we hold, please write to us at 3rd Floor, Hollywood House, Church Street East, Woking, GU21 6HJ. Any access request may be subject to a fee of £10 to meet our costs in providing you with details of the information we hold about you.


The data that we collect from you may be transferred to, and stored at, a destination outside the European Economic Area (“EEA”). It may be processed by staff operating outside the EEA who work for us or for one of our suppliers. Such staff may be engaged in, amongst other things, the provision of support services. By submitting your personal data, you agree to this transfer, storing and processing. We will take all steps reasonably necessary, including the use of encryption, to ensure that your data is treated securely and in accordance with this privacy policy.

Unfortunately, the transmission of information via the internet is not completely secure. Although we will do our best to protect your personal data, we cannot guarantee the security of your data transmitted to our sites; any transmission is at your own risk. You will not hold us responsible for any breach of security unless we have been negligent or in wilful default.


Any changes we make to our privacy policy in the future will be posted on this page and, where appropriate, notified to you by e-mail.


Our sites contain links to other websites. If you follow a link to any of these websites, please note that these websites have their own privacy policies and that we do not accept any responsibility or liability for these policies. Please check these policies before you submit any personal data to these websites.


If you want more information or have any questions or comments relating to our privacy policy please email [email protected] in the first instance.

 Information  X 
Enter a valid email address

Recent News

Monday 11 May, 2015

11-May-2015 04:26 PM

Dutch regulator approves Chesnara acquisition of Waard

Chesnara's acquisition of Waard Group has been approved by the Dutch regulator, De Nederlandsche Bank N.V. Chesnara announced its intention to acquire Waard in the Netherlands for an initial consideration of £55.1m on 3 December. Completion of t
11-May-2015 04:02 PM

Market Movers - Top risers and fallers between 15:00 and 16:00

Overall Market Tandem Group 150.00 +1.69% Porvair 314.00 +0.48% Blinkx 38.38 +0.34% Hochschild Mining 103.25
11-May-2015 04:00 PM

Market Movers - Top risers and fallers at 16:00

FTSE 100 Royal Mail 498.85 +4.17% Taylor Wimpey 181.00 +3.02% Sage Group (The) 557.75 +2.62% Hikma Pharmaceuticals 2057.00 +2.
11-May-2015 03:46 PM

HSS Hire Group schedules AGM

HSS Hire Group will hold its annual general meeting at Haberdashers' Hall, 18 West Smithfield, London EC1A 9HQ, on 16 June at 2.30 p.m. At 3:46pm: (LON:HSS) HSS Hire Grp Plc share price was +4.25p at 198.25p Story provided by
11-May-2015 03:31 PM

GW chief executive to present at Las Vegas conference

GW Pharmaceuticals chief executive Justin Gover is scheduled to present at the Bank of America Merrill Lynch 2015 Healthcare Conference to be held at Encore at the Wynn in Las Vegas, NV tomorrow (12 May) at 4:20 p.m. PT. A live audio webcast of the pres
11-May-2015 03:23 PM

Feedback delighted with results from study

Feedback is delighted with positive results from a preliminary study using its TexRAD research software in the analysis of kidney stones are promising. Feedback announced on 13 April tjhat it had signed a research agreement with the Oxford Stone Group at
11-May-2015 03:09 PM

US Labor Market Conditions Index at -1.9

The US Labor Market Conditions Index stood at -1.9 in April compared with -0.3 previously, the US Federal Reserve said today. Story provided by
11-May-2015 03:02 PM

Market Movers - Top risers and fallers between 14:00 and 15:00

Overall Market Highcroft Inv. 900.00 +1.12% Advance Developing Markets Fd 472.75 +0.83% Igas Energy 35.50 +0.71% GW Pharmaceuticals 603.75
11-May-2015 03:00 PM

Market Movers - Top risers and fallers at 15:00

FTSE 100 Royal Mail 501.50 +4.72% Sage Group (The) 560.25 +3.08% Taylor Wimpey 180.50 +2.73% 3i Group 514.75 +2.
11-May-2015 02:30 PM

New World update on proposed open offer

New World Oil and Gas has confirmed that further to the announcement of 5 May, it is making arrangements to proceed with an open offer. The detailed terms of this and the requisite timetable (including record date) will be announced in due course. Given
11-May-2015 02:08 PM

CBI urges government to set out business plan

Britain's bosses have urged the Government to set out a clear business plan for its first 100 days. The Confederation of British Industry says this includes getting the deficit down, finding new ways to deliver public services and committing to the
11-May-2015 02:02 PM

Market Movers - Top risers and fallers between 13:00 and 14:00

Overall Market Canadian Overseas Petroleum Limited 5.50 +2.23% CEB Resources 0.68 +1.49% CAP-XX 4.13 +1.23% LPA Group 71.50
11-May-2015 02:00 PM

Market Movers - Top risers and fallers at 14:00

FTSE 100 Royal Mail 497.95 +3.98% Sage Group (The) 560.75 +3.17% Taylor Wimpey 180.20 +2.56% Hikma Pharmaceuticals 2054.50 +2.
11-May-2015 01:42 PM

Skipton completes sale of Pearson Jones

Skipton Building Society has completed the sale of its wealth management specialist business, Pearson Jones, to Standard Life plc. Story provided by
11-May-2015 01:41 PM

European REIT resolutions passed at AGM

European Real Estate Investment Trust has confirmed that all resolutions proposed at its annual general meeting today were passed. At 1:41pm: (LON:ERET) European Real Estate Inv Trust Ltd share price was 0p at 102.5p Story provided by StockMarketWire
11-May-2015 01:30 PM

Finsbury Growth & Income beats benchmark

Finsbury Growth & Income Trust's net asset value per share rose by 17.3% in the six months to the end of March on a total return basis. This compares with a 5.3% rise in its benchmark, the FTSE All-Share Index on a total return basis. The company&ap
11-May-2015 01:17 PM

Verizon operations president to present in Miami

Verizon Communications' executive vice-president and president of operations John Stratton will speak at the Jefferies Technology, Media and Telecom conference in Miami tomorrow (12 May). His presentation will be webcast beginning at approximately 8
11-May-2015 01:05 PM

Greene King to offer Spirit Pub undertakings

Greene King has noted that its recommended offer for Spirit Pub Co will be referred for a phase 2 investigation by the Competition and Markets Authority unless undertakings to address competition concerns are offered. Greene King says it is cooperating
11-May-2015 01:02 PM

Market Movers - Top risers and fallers between 12:00 and 13:00

Overall Market Lekoil 20.50 +0.59% Foxtons Group 255.63 +0.35% Novae Group 690.50 +0.33% Brown (N) Group 337.85
11-May-2015 01:01 PM

Silence Therapeutics schedules AGM

Silence Therapeutics will hold its annual general meeting at its offices at 1 Lyric Square, London, W6 0NB, on 1 June at 10 a.m. At 1:01pm: (LON:SLN) Silence Therapeutics PLC share price was -4.5p at 302.5p Story provided by
11-May-2015 01:00 PM

Market Movers - Top risers and fallers at 13:00

FTSE 100 Royal Mail 495.60 +3.49% Sage Group (The) 560.25 +3.08% Hikma Pharmaceuticals 2057.50 +2.36% 3i Group 512.75 +2.
11-May-2015 12:50 PM

Board changes at Asia Ceramic Holdings

Asia Ceramics Holdings has appointed Marcus Nicola Paciocco as a non- executive director. Alei Duan, a non-executive director, will move to be non-executive chairman with immediate effect replacing Frank Lewis who will now step down. The company has als
11-May-2015 12:42 PM

Brokers' round-up, downgrades for Inchcape and JD Sports

Deutsche Banks cuts Inchcape to hold from buy, target raised from 800p to 885p. N + 1 Singer cuts JD Sports Fashion to hold from buy, target 655p. Numis cuts Diploma to hold from add, 843p target unchanged. Numis cuts Hunting to hold from buy, 554p tar
11-May-2015 12:21 PM

New chairman at Epistem Holdings

Dr Ian Gilham has been appointed as non-executive chairman of Epistem Holdings. He was appointed to the Board as a non-executive director and chairman designate last November. He succeeds David Evans as chairman who has also retired as a director. A
11-May-2015 12:16 PM

Half year losses grow at GW Pharmaceuticals

GW Pharmaceuticals, a biopharmaceutical company focused on discovering, developing and commercialising novel therapeutics from its proprietary cannabinoid product platform, has announced that revenue for the six months ended 31 March 2015 was £14.3m comp

a d v e r t i s e m e n t